EXPERIENCE IN OUR CENTER WITH THE USE OF RITUXIMAB - VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Pimentel, Villar Ma [1 ]
De Leon, Marcano E. [1 ]
Jimenez, Moreno M. [1 ]
Lopez, Marquez T. J. [1 ]
Almagro, Torres F. [1 ]
Lopez, Lopez J. A. [1 ]
机构：
[1] Hosp Univ Jaen, Jaen, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-049
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [31] Venetoclax for the treatment of patients with chronic lymphocytic leukemia
    Crombie, Jennifer
    Davids, Matthew S.
    FUTURE ONCOLOGY, 2017, 13 (14) : 1223 - 1232
  • [32] An update on the efficacy of Venetoclax for chronic lymphocytic leukemia
    Lovell, Alexandra R.
    Sawyers, Jacki
    Bose, Prithviraj
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (11) : 1307 - 1316
  • [33] Emerging Data for Venetoclax in Chronic Lymphocytic Leukemia
    O'Brien, Susan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (03) : 178 - 183
  • [34] Patterns of Venetoclax Sensitivity in Chronic Lymphocytic Leukemia
    Dibb, James T.
    Long, Nicola
    Eide, Christopher A.
    Kurtz, Stephen E.
    Tognon, Cristina E.
    Tyner, Jeffrey W.
    Druker, Brian J.
    BLOOD, 2020, 136
  • [35] Mechanisms of Venetoclax Resistance in Chronic Lymphocytic Leukemia
    Frenzel, Lukas P.
    Herling, Carmen D.
    Abedpour, Nima
    Weiss, Jonathan
    Mayer, Petra
    Cartolano, Maria
    Berg, Valeska
    Kutsch, Nadine
    Cramer, Paula
    Wendtner, Clemens-Martin
    Persigehl, Thorsten
    Saleh, Andreas
    Altmueller, Janine
    Nurnberg, Peter
    Pallasch, Christian
    Achter, Viktor
    Lang, Ulrich
    Eichhorst, Barbara F.
    Castiglione, Roberta
    Schaefer, Stephan C.
    Buettner, Reinhard
    Kreuzer, Karl-Anton
    Reinhardt, Hans Christian
    Hallek, Michael J.
    Peifer, Martin
    BLOOD, 2017, 130
  • [36] An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Salvaris, Ross
    Opat, Stephen
    FUTURE ONCOLOGY, 2020, 17 (04) : 371 - 387
  • [37] Chronic lymphocytic leukemia in Turkey:: Experience of a single center in Istanbul
    Pamuk, ON
    Pamuk, GE
    Soysal, T
    Öngören, N
    Baslar, ZB
    Ferhanoglu, B
    Aydin, Y
    Ülkü, B
    Aktuglu, G
    Akman, N
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (03) : 240 - 245
  • [38] HTA: EFFICACY AND SAFETY OF THE USE OF RITUXIMAB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Souza, K. M.
    Koury, C. D. N.
    Nunes, A. A.
    VALUE IN HEALTH, 2013, 16 (07) : A683 - A683
  • [39] Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia
    Al-Sawaf, Othman
    Herling, Carmen Diana
    Holtick, Udo
    Scheid, Christoph
    Cramer, Paula
    Sasse, Stephanie
    von Tresckow, Bastian
    Tuchscherer, Armin
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    Frenzel, Lukas P.
    HAEMATOLOGICA, 2019, 104 (05) : E224 - E226
  • [40] The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
    Schieber, Michael
    Ma, Shuo
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 9 - 17
12345